Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
67.28%
80%
—
—
40%
—
5 Years
Score—
Net Growth67.28%
Net Trend80%
Net Income Consistency—
Rev Growth—
Rev Trend40%
Revenue Consistency—
Aprea Therapeutics Inc fundamental performance
Across Aprea Therapeutics Inc's full reported history, from 2019 to 2025, revenue grew from $ 0.00 to $ 285.76K and net income went from -$ 28M to -$ 12M. Revenue increased in 29% of the years measured; net income in 71%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.68 | — |
1 Year2025-08-12 | $ 1.70 | -59.82% |
5 Years2021-08-12 | $ 80.80 | -99.15% |
All Time2019-10-03 | $ 410.00 | -99.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-10-03 |
|---|---|---|---|---|
| Price | $ 0.68 | $ 1.70 | $ 80.80 | $ 410.00 |
| Return | — | -59.82% | -99.15% | -99.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 123.3K | -$ 11M | $ 46M |
| 2025 | $ 285.76K | -$ 12M | $ 14M |
| 2024 | $ 1M | -$ 12M | $ 22M |
| 2023 | $ 583.23K | -$ 14M | $ 21M |
| 2022 | $ 0.00 | -$ 112M | $ 28M |
| 2021 | $ 0.00 | -$ 36M | $ 53M |
| 2020 | $ 0.00 | -$ 53M | $ 89M |
| IPO2019 | $ 0.00 | -$ 28M | $ 130M |
Explore beyond APRE
You're looking at Aprea Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
